European journal of breast health最新文献

{"title":"Analysis of Knowledge About Male Breast Cancer Among Higher Education Male Students.","authors":"Eduarda Hiss Faria,&nbsp;Dirrieh Kim,&nbsp;Rafaela Melo Sisconetto,&nbsp;Vitória Flávia Melo Cucio,&nbsp;Pedro Paulo Guerreiro Dos Reis Ferreira,&nbsp;Bruna Silva Rodrigues Alves,&nbsp;Ígor Mendes Macedo Mendonça,&nbsp;Maite Rocha Oliveira,&nbsp;Anna Leticia Barbosa Vicente,&nbsp;Jeniffer Cristine Alves,&nbsp;Douglas Reis Abdalla","doi":"10.4274/ejbh.galenos.2021.2021-4-6","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2021.2021-4-6","url":null,"abstract":"<p><strong>Objective: </strong>Breast cancer is the most common cancer among women, both in Brazil and worldwide. Breast cancer can also affects men but this constitutes only 1% of cases and is thus considered rare, and for this reason is little studied. Statistics indicate an increase in its incidence with an estimate of new cases in recent years. This study aims to analyze the knowledge of higher education students in relation to breast cancer in men. the knowledge of higher education students in relation to breast cancer in men.</p><p><strong>Materials and methods: </strong>Exploratory study with a quantitative approach. 299 male students participated in the study. Data collection took place through semi-structured questionnaires, completed by students from pure science, human sciences and health at a higher education institution.</p><p><strong>Results: </strong>Regardless of the area of undergraduate study, 65.9% of the volunteers reported not knowing about breast cancer in men. Regarding predisposing factors for the development of breast cancer, 77.3% reported not knowing about these while 68.9% reported not knowing about breast self-examination. However, 67.6% believe that breast cancer in men can be prevented. Worryingly, 62.5% reported that they only seek medical assistance when becoming ill.</p><p><strong>Conclusion: </strong>Evidence from this study suggests that higher level undergraduates have limited knowledge about breast cancer in men. Only one third knew that male breast cancer was possible. Even smaller proportions knew of the predisposing factors for breast cancer, how to perform self-examination and about diagnosis. These latter factors, when combined with a tendency to seek medical help only when ill, suggests a short-fall in health knowledge which should be corrected.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"333-340"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496119/pdf/ejbh-17-333.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39519543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of Primary Tumor Resection on Metastatic Breast Cancer Survival and the Predictive Power of Neutrophil: Lymphocyte Ratio on Prognosis.","authors":"Yaşar Çöpelci,&nbsp;Umut Rıza Gündüz,&nbsp;Bülent Dinç,&nbsp;Nurhan Haluk Belen,&nbsp;Şeyda Gündüz","doi":"10.4274/ejbh.galenos.2021.2021-3-2","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2021.2021-3-2","url":null,"abstract":"<p><strong>Objective: </strong>The aim was to investigate the effect of primary tumor resection (PTR) on survival in metastatic breast cancer patients and to assess the power of the neutrophil-to-lymphocyte ratio (NLR) regarding the prediction of prognosis in this patient group.</p><p><strong>Materials and methods: </strong>Female patients diagnosed with and starting treatment for metastatic breast cancer from 2003 to 2016 in the general surgery and oncology clinics at a single center were retrospectively reviewed. Pre-treatment NLR value and survival situations were evaluated.</p><p><strong>Results: </strong>A total of 117 patients were enrolled. The disease-specific survival (DSS) of the patients was 41.4 months. When stratified into PTR and systemic treatment (ST) groups, there was no difference in the survival (p = 0.054); 43.5 months in the PTR group vs 30.7 months in the ST group. When hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative subgroups were analyzed, DSS was significantly longer (p = 0.02) in the PTR group (55.4 months) compared to the ST group (41.8 months). Finally, in patients with an NLR of <2.3, DSS was significantly longer (p = 0.03) in the PTR group (56.1 months) compared to the ST group (25.2 months).</p><p><strong>Conclusion: </strong>These results suggest that DSS can be increased with PTR in selected patients with a diagnosis of metastatic breast cancer. NLR may be useful in selecting patients for appropraite treatment modality.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"322-327"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496121/pdf/ejbh-17-322.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39519573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effect of Breast Size and Density in Turkish Women on Radiation Dose in Full-Field Digital Mammography.","authors":"Ayşegül İdil Soylu,&nbsp;Mesut Öztürk,&nbsp;Ahmet Veysel Polat","doi":"10.4274/ejbh.galenos.2021.6285","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2021.6285","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to look into the relationship between breast size and mammographic breast density in women and breast radiation dose on full-field digital mammography (FFDM), as well as the factors that influence radiation dose.</p><p><strong>Materials and methods: </strong>The study included a total of 2,060 FFDM images from 515 consecutive participants. The participants were divided into two groups: those exposed to high doses (>3 mGy) and those exposed to low doses (<3 mGy). Moreover, the researchers analyzed the relationship between mean glandular dose (MGD) of the breast and patient age, compressed breast thickness, compression force, mammographic breast composition, and mammographic breast size.</p><p><strong>Results: </strong>The mean mammographic breast volume was 936.2 ± 425.2 (114.5-3,018) mL, and the mean compressed breast tissue thickness was 56.75 ± 10.44 mm. Moreover, the mean MGD in the high-dose group was 3.51 ± 0.48 mGy and 1.92 ± 0.56 mGy in the low-dose group. The high-dose group had greater breast thickness, diameters, volume, compression pressure, and surgical rate. However, the high-dose group was younger and had less dense breasts. In multivariate logistic regression analysis, the most important predictors of dose determination were breast thickness [odds ratio (OR): 1.178, 95% confidence interval (CI): 1.156-1.200, p<0.001], history of previous surgery (OR: 2.210, 95% CI: 1.417-3.447, p<0.001), compression force (OR: 1.008, 95% CI: 1.004-1.013, p<0.001), and breast density (OR: 1.873, 95% CI: 1.359-2.580, p<0.001).</p><p><strong>Conclusion: </strong>Women with larger breast volumes are subjected to higher doses of radiation. Therefore, breast-screening programs can be individualized to young women with larger breast volumes and women who have had breast-conserving surgery.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"315-321"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496124/pdf/ejbh-17-315.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39519572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Chest Wall Silicone Granuloma Following Ruptured Silicone Breast Implant Causes Giant Chest Wall Abscess and Osteomyelitis: The First Report.","authors":"Hanad Ahmed,&nbsp;Alessandro Tamburrini,&nbsp;Mansoor Khan,&nbsp;Aiman Alzetani","doi":"10.4274/ejbh.galenos.2020.5971","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2020.5971","url":null,"abstract":"<p><p>Silicone breast implant ruptures have been widely reported in the literature. Granuloma formation is a known complication of such ruptures with reported sites including the axillae, limbs, chest wall muscles, and internal organs, such as the lungs and the liver. To the best of our knowledge, there are no reported cases of a silicone granuloma causing osteomyelitis of the sternum and multiple ribs in the absence of infection. We therefore report on the case of an 81-year-old patient who presented with an anterior chest wall discharging sinus tract on the background of a ruptured silicone breast implant. We raise awareness about the potentially devastating complications resulting from a ruptured silicone implant with relevance to cardiothoracic practice.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"383-385"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496115/pdf/ejbh-17-383.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39544358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Expression of Galectin-3 in Tumor and Cancer-Associated Fibroblasts in Invasive Micropapillary Breast Carcinomas: Relationship with Clinicopathologic Parameters.","authors":"Yasemin Çakır,&nbsp;Canan Kelten Talu,&nbsp;Özlem Mermut,&nbsp;Didem Can Trabulus,&nbsp;Esra Arslan","doi":"10.4274/ejbh.galenos.2021.2021-2-8","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2021.2021-2-8","url":null,"abstract":"<p><strong>Objective: </strong>Galectin-3 affects tumor progression and cell surface polarization by expressing from the tumor and cancer-associated fibroblasts (CAFs). Therefore, it may have a role on micropapillary carcinomas (IMPC), which have characteristic morphological features. The aim was to investigate the expression levels of Galectin-3 within tumor and peritumoral CAFs in IMPC, and to compare with expression in invasive ductal carcinomas (IDC).</p><p><strong>Materials and methods: </strong>Hematoxylin and Eosin-stained preparations of resection materials examined between 2010-2016 were re-evaluated. Thirty-four IMPC cases and 34 IDC cases with similar molecular subtype distribution to IMPC were compared. Galectin-3 levels were evaluated with a calculated H-score in tumor and semi-quantitatively in CAFs.</p><p><strong>Results: </strong>While tumoral Galectin-3 expression levels were higher in IMPCs compared to IDCs, there was no difference for Galectin-3 expression in CAFs between the two histologic types. However, there was no significant relationship between tumoral Galectin-3 expression and clinicopathological parameters in IMPCs. When the subjects were divided into two groups, depending on their Galectin-3 status regardless of histological types, the loss of Galectin-3 expression in tumor was found to be related to larger tumor size/advanced pT stage and a greater number of metastatic nodes. Additionally, expression of Galectin-3 in CAFs was found to be associated with distant metastasis.</p><p><strong>Conclusion: </strong>IMPC showed prominent Galectin-3 expression in tumor compared to IDC. However, independent from the histological type, whereas the loss of Galectin-3 expression in tumor showed an association with larger tumor size and higher number of metastatic axillary lymph nodes, the presence of Galectin-3 expression in CAFs showed an association with distant metastasis.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"341-351"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496113/pdf/ejbh-17-341.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39519544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma.","authors":"Paul Ionescu, Florence Vibert, Shanti Amé, Carole Mathelin","doi":"10.4274/ejbh.galenos.2021.2021-5-6","DOIUrl":"10.4274/ejbh.galenos.2021.2021-5-6","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to illustrate the epidemiological situation of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) by focusing on the changes published after 2019 and particularly the new approaches of cosmetic and reconstructive breast surgery.</p><p><strong>Materials and methods: </strong>Article search was performed from January 2019 to date using the PubMed database. Fourteen articles were included in the qualitative evaluation of international data. Moreover, the latest reports regarding the total number of BIA-ALCL cases and number of deaths were identified.</p><p><strong>Results: </strong>Estimates of the risk and incidence have increased significantly recently, affecting 1 in every 2,969 women with breast implants and 1 in 355 patients with textured implants after breast reconstruction. The average exposure time to diagnosis was 8 (range: 0-34) years. Approximately 80% of BIA-ALCL cases were diagnosed at IA-IIA stages, for which the treatment was breast implant removal, full capsulectomy, and excision of all suspected lymph nodes. Globally, at least 949 cases were reported to date.</p><p><strong>Conclusion: </strong>At present, BIA-ALCL is an emerging pathology of interest. Data collection initiated since 2016 through different case registration databases is essential to ensure surveillance and to continue to increase the number of studies on this recently discovered pathology.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"302-307"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496114/pdf/ejbh-17-302.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39519570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stewart-Treves Syndrome: A Rare But Aggressive Complication of Breast Cancer-Related Lymphedema.","authors":"Pınar Borman,&nbsp;Ayşegül Yaman,&nbsp;Özay Gököz","doi":"10.4274/ejbh.galenos.2020.5741","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2020.5741","url":null,"abstract":"<p><p>Stewart-Treves syndrome (STS) is an angiosarcoma that usually develop in an extremity with longstanding lymphedema. Most affected patients have a history of breast cancer treated with radical mastectomy. Here, we report a case of STS with breast cancer-related lymphedema (BCRL) for a period of seven years. A 56-year-old woman presented with chronic lymphedema of the left arm. Nine years previously she had modified radical mastectomy for grade 2, invasive, ductal breast cancer. Upon physical examination, a tender, purplish lesion on the medial half of the affected arm was observed. The lesion spread rapidly with different-sized, scattered, purple-colored lesions in the affected area. A prompt skin biopsy was reported as STS. An immediate arm amputation was performed. However, a few months later she presented with new lesions on the anterior thorax and subsequent local recurrence around the scar. She received radiation-therapy. However, six months later the angiosarcoma had spread to the pelvic and upper limb area with scattered skin lesions. She had several problems during the chemotherapy and radiation-therapy, although she survived beyond 20 months. In conclusion, STS is a rare but aggressive and important complication of BCRL. Awareness of rapidly progressing skin lesions and detailed investigation, as well as prompt surgery is necessary for patients with BCRL in order to relatively increase the survival time.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"378-382"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496122/pdf/ejbh-17-378.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39519549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Favorable Personality Traits in Women Who Have Undergone Cosmetic Breast Augmentation Surgery.","authors":"Güncel Öztürk,&nbsp;Elmas Beyazyüz,&nbsp;Yakup Albayrak,&nbsp;Murat Beyazyüz","doi":"10.4274/ejbh.galenos.2020.6276","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2020.6276","url":null,"abstract":"<p><strong>Objective: </strong>Breast augmentation surgery is one of the most common cosmetic procedures among women. In the present study, we compared personality traits, self-esteem, and body perception between women who had undergone breast augmentation surgery and a control group of women who had not. We hypothesized that the personality traits of women who had vs those who had not undergone breast augmentation surgery would differ.</p><p><strong>Materials and methods: </strong>According to the inclusion and exclusion criteria, patients who had undergone breast augmentation surgery and age- and education-matched, healthy women were included in the present study. The breast augmentation group and control group were compared in terms of personality traits under the Basic Personality Traits Inventory. Additionally, self-esteem, which was assessed with the Rosenberg Self-Esteem Scale, and body perception, which was evaluated using the Body Cathexis Scale, were measured and compared between the two groups.</p><p><strong>Results: </strong>When the patients (n = 80) and the control group (n = 100) were compared, the Body Cathexis Scale, extroversion, and openness scores were statistically significant and were found to be higher in the breast augmentation group (p<0.05). In regression analysis, it was found that age, openness, and the Rosenberg Self-Esteem Scale score had statistically significant effects on extroversion.</p><p><strong>Conclusion: </strong>We argue that there may be a presupposition, based on stigma, that women who undergo breast augmentation surgery are more neurotic than those who do not. Consequently, this may influence the outcomes of studies evaluating the personalities of these women. Our results indicate that women who had undergone breast augmentation had more positive personality traits than women in an un-operated control group.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"308-314"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496111/pdf/ejbh-17-308.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39519571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Indocyanine Green Fluorescence-Guided Sentinel Node Biopsy in Breast Cancer Within a North African Population: A Retrospective Study.","authors":"Samir Hidar,&nbsp;Amal Alimi,&nbsp;Abdejlil Khlifi,&nbsp;Selma Chachia,&nbsp;Ons Kaabia,&nbsp;Sassi Bouguizane,&nbsp;Mohamed Bibi,&nbsp;Hédi Khairi","doi":"10.4274/ejbh.galenos.2021.2021-4-11","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2021.2021-4-11","url":null,"abstract":"<p><strong>Objective: </strong>Radio isotopes and blue dyes alone or in combination are the most commonly used tracer agents in sentinel node (SN) biopsy for early breast cancer. Recent studies have found fluorescence method using indocyanine green (ICG) as a promising technology with fewer disadvantages.</p><p><strong>Materials and methods: </strong>Retrospective analysis of our database that included patients with clinically node-negative breast cancer scheduled for breast surgery and SN biopsy between 2016 and January 2021. Patients who underwent detection using fluorescence-ICG were included in this study.</p><p><strong>Results: </strong>A total of 47 patients were included. Median age was 50 (range: 24-78) years. Mean tumor size was 3.4 ± 1.5 cm. All patients received ICG injection and 11 received a combination of ICG and blue dye. Forty-five successful SN identifications with ICG were performed and 99 nodes retrieved. Eleven procedures were undertaken after initial systemic therapy. Twenty-four patients had at least one positive SN for malignancy. Mean follow up was 29.2 months and no axillary recurrence was noted during the study period.</p><p><strong>Conclusion: </strong>ICG appears to be a feasible and accurate method for SN biopsy with high identification rate. This is the first study of ICG in sentinel node biopsy in a North African population.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"352-355"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496117/pdf/ejbh-17-352.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39519545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Value-Based Quality Care for Breast Cancer: More Than Guidelines.","authors":"Nuh Zafer Cantürk, Bahadır M Güllüoğlu","doi":"10.4274/ejbh.galenos.2021.6333","DOIUrl":"10.4274/ejbh.galenos.2021.6333","url":null,"abstract":"<p><p>Although guidelines recommend some of the most expensive diagnostic methods and therapies, some patients do have the opportunity to use them, but some others have overused or misused such methods. The cost of cancer care is increasing, but the satisfaction levels of patients and healthcare workers have not increased in line with this rise. Value-based care for cancer, especially breast cancer, should be implemented. For this reason, all unnecessary screening, tests, treatments, and follow-up parameters should be avoided.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":"17 4","pages":"297-301"},"PeriodicalIF":0.0,"publicationDate":"2021-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496118/pdf/ejbh-17-297.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39519569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}